欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0977/001
药品名称Azacitidin Hikma 25 mg/ml Pulver zur Herstellung einer Injektionssuspension
活性成分
    • Azacitidine 25.0 mg/ml
剂型Powder and solvent for suspension for injection
上市许可持有人Hikma Farmaceutica (Portugal) S.A. Estrada do Rio da Mó, 8, 8A, 8B, Fervença 2705 906 Terrugem Sintra Portugal
参考成员国 - 产品名称Austria (AT)
Azacitidin Hikma
互认成员国 - 产品名称
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • United Kingdom (Northern Ireland) (XI)
    • Denmark (DK)
      Azacitidine "Hikma"
    • Belgium (BE)
      NL Azacitidine Hikma 25 mg/ml poeder voor suspensie voor injectie / FR Azacitidine Hikma 25 mg/ml poudre pour suspension injectable / DE Azacitidin Hikma 25 mg/ml Pulver zur Herstellung einer Injektio
    • Sweden (SE)
    • Germany (DE)
      Azacitidin Hikma 25 mg/ml Pulver zur Herstellung einer Injektionssuspension
    • Norway (NO)
    • Netherlands (NL)
    • Finland (FI)
    • France (FR)
许可日期2022/03/28
最近更新日期2024/12/23
药物ATC编码
    • L01BC07 azacitidine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase